Brain Tumor Funders’ Collaborative Aims to Spur Development of Non-Invasive Response Markers for Human Gliomas
WASHINGTON–(BUSINESS WIRE)–Today, the eight North American private funding organizations comprising the Brain Tumor Funders’ Collaborative announced a new funding initiative aimed at accelerating development of non- or minimally-invasive methods for monitoring if, when, and how human brain tumors are responding to investigational therapies. This represents the second round of funding offered by a unique collaborative funding effort representing private foundations and patient advocacy groups. The BTFC inaugurated its funding program in 2005, awarding grants to three multi-institutional, collaborative research projects. The BTFC’s primary goal is bridging the “translational gap” that can prevent promising laboratory findings from yielding new medical treatments. In…
Read the full news release on BusinessWire.com
